Projected Income Statement: Orange

Forecast Balance Sheet: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 24,269 25,298 27,002 22,482 22,526 31,139 29,707 28,406
Change - 4.24% 6.74% -16.74% 0.2% 38.24% -4.6% -4.38%
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 18/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 7,660 7,371 6,815 6,425 6,208 6,293 6,301 6,216
Change - -3.77% -7.54% -5.72% -3.38% 1.37% 0.13% -1.36%
Free Cash Flow (FCF) 1 3,576 3,864 5,239 3,770 4,572 3,806 4,084 4,721
Change - 8.05% 35.58% -28.04% 21.27% -16.76% 7.31% 15.6%
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 18/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 29.55% 29.82% 29.54% 30.08% 30.87% 31.82% 32.42% 32.97%
EBIT Margin (%) 18.74% 13.67% 12.71% 13.63% 11.31% 15.33% 16.03% 16.8%
EBT Margin (%) 4.09% 8.93% 8.53% 10.57% 5.47% 12.49% 13.58% 14.57%
Net margin (%) 0.55% 4.94% 5.53% 5.84% 1.33% 7.22% 7.81% 8.28%
FCF margin (%) 8.41% 8.89% 11.87% 9.36% 11.32% 9.34% 9.92% 11.3%
FCF / Net Income (%) 1,534.76% 180.06% 214.71% 160.43% 849.81% 129.32% 127.02% 136.43%

Profitability

        
ROA 0.22% 1.97% 2.22% 2.2% 0.51% 2.92% 3.11% 3.29%
ROE 6.1% 6.69% 7.67% 7.39% 1.75% 9.02% 9.72% 9.92%

Financial Health

        
Leverage (Debt/EBITDA) 1.93x 1.95x 2.07x 1.86x 1.81x 2.4x 2.23x 2.06x
Debt / Free cash flow 6.79x 6.55x 5.15x 5.96x 4.93x 8.18x 7.27x 6.02x

Capital Intensity

        
CAPEX / Current Assets (%) 18.01% 16.96% 15.45% 15.96% 15.37% 15.44% 15.3% 14.88%
CAPEX / EBITDA (%) 60.96% 56.86% 52.28% 53.06% 49.78% 48.54% 47.2% 45.13%
CAPEX / FCF (%) 214.21% 190.76% 130.08% 170.42% 135.78% 165.35% 154.28% 131.66%

Items per share

        
Cash flow per share 1 4.228 4.182 4.531 3.833 4.052 3.732 3.816 3.948
Change - -1.09% 8.35% -15.4% 5.72% -7.89% 2.25% 3.45%
Dividend per Share 1 0.7 0.7 0.7 0.72 0.75 0.785 0.8217 0.8498
Change - 0% 0% 2.86% 4.17% 4.67% 4.68% 3.42%
Book Value Per Share 1 12.16 11.96 11.97 11.95 11.19 11.45 11.7 11.81
Change - -1.66% 0.1% -0.14% -6.39% 2.31% 2.21% 0.97%
EPS 1 - 0.73 0.85 0.82 0.14 1.122 1.233 1.292
Change - - 16.44% -3.53% -82.93% 701.7% 9.86% 4.76%
Nbr of stocks (in thousands) 2,631,971 2,657,122 2,659,182 2,658,153 2,658,600 2,658,300 2,658,300 2,658,300
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 18/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 16x 14.6x
PBR 1.57x 1.53x
EV / Sales 1.94x 1.88x
Yield 4.37% 4.58%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
17.94EUR
Average target price
17.98EUR
Spread / Average Target
+0.21%

Quarterly revenue - Rate of surprise